Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Part 1: When to test
PARP inhibition in the treatment of prostate cancer
Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 2: Who to test
PARP inhibition in the treatment of prostate cancer
Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 3: How to test
PARP inhibition in the treatment of prostate cancer
Part 3: How to test ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 4: Metastatic prostate cancer and HRR defects
PARP inhibition in the treatment of prostate cancer
Part 4: Metastatic prostate cancer and HRR defects ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
Part 5: BRCA 1/2 mutations and prostate cancer
PARP inhibition in the treatment of prostate cancer
Part 5: BRCA 1/2 mutations and prostate cancer ( PARP inhibition in the treatment of prostate cancer )
23 Jul 2021
The role of testing in prostate cancer treatment
Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki
The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )
20 Jul 2021
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invasive bladder cancer ( Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy )
19 Jul 2021
Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC a...
Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China
Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021 ( Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China )
16 Jul 2021
Lineage plasticity in lung cancer- biological and therapeutic implications
Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
Lineage plasticity in lung cancer- biological and therapeutic implications ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )
16 Jul 2021
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-...
Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell Med...
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION) ( Dr Michael Morris - Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, USA )
15 Jul 2021
OncoAlert and ecancer weekly round up for July 1- July 10, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for July 1- July 10, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
13 Jul 2021
ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R B...
Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
ZUMA-3: KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy for R/R B-cell acute lymphoblastic leukaemia ( Dr Bijal Shah - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
12 Jul 2021